Ionis Pharmaceuticals Inc
IONS· Nasdaq
Released Feb 21, 2024, during market hours
10-K filed Feb 21, 2024, 52 days after period end · 0000874015-24-000116
| Metric | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $324.51M | $151.89M | $440.01M | $290.28M |
| Net Income | -$9.26M | -$52.43M | $224.61M | -$354.53M |
| EPS Diluted |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.06 |
| -$0.37 |
| $1.41 |
| -$2.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.